Literature DB >> 218892

Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.

K Takada, T Osato.   

Abstract

A B-cell population of human cord blood lymphocytes was exposed to the B95-8 strain of Epstein-Barr virus (EBV), and simultaneous observations of immunofluorescence, cellular morphology and autoradiography were carried out in each individual cell. It was evident that EBV-determined nuclear antigen (EBNA) synthesis occurred prior to blastogenic response and DNA synthesis. EBNA-positive cells could be observed as early as 12 h after infection and reached a maximum of 17% at 24 h, followed by a plateau for a subsequent 12 h. The positive cells were seen exclusively as morphologically normal lymphocytes until 18 h; at 24 h, blastogenesis became evident, without cell division. DNA synthesis was detected at 36 h in EBNA-positive blast cells, after which these cells increased rapidly. EBNA synthesis was similarly evident in the presence of cytosine arabinoside, but was significantly inhibited by a short-term exposure to cycloheximide immediately after infection. These findings suggest that the early events in EBV-induced transformation of human lymphocytes occur sequentially from EBNA synthesis, to blastogenesis, to DNA synthesis and that the crucial step of such transformation is probably involved in protein synthesis occurring in the very early stage of EBV infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218892     DOI: 10.1159/000149009

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  7 in total

1.  Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

Authors:  K P Mann; D Staunton; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

2.  A routine method for the establishment of permanent growing lymphoblastoid cell lines.

Authors:  H Neitzel
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

3.  Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.

Authors:  F V Chisari; L K Curtiss; F C Jensen
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

4.  Epstein-Barr virus in adult T-cell leukemia/lymphoma.

Authors:  M Tokunaga; S Imai; Y Uemura; T Tokudome; T Osato; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

5.  Dimer-size DNA circles in a leukemic cell immortalized with the Epstein-Barr virus.

Authors:  E Gussander; A Adams
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes.

Authors:  C Alfieri; A C Allison; E Kieff
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

7.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.

Authors:  K Takada; T Osato
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.